Compound 3k (C3k) is a selective PKM2 inhibitor that shows anti-tumor activity in various types of cancer cells with high PKM2 expression such as colon cancer (HCT116) and cervical cancer (HeLa) [121]. Here, PKM is linked to colonic neoplasm.